Joseph Joshua J, Wang Xu, Spanakis Elias, Seeman Teresa, Wand Gary, Needham Belinda, Golden Sherita Hill
Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, United States.
School of Public Health, Drexel University, Philadelphia, PA, United States.
Psychoneuroendocrinology. 2015 Dec;62:327-35. doi: 10.1016/j.psyneuen.2015.08.021. Epub 2015 Aug 28.
Hypercortisolism is associated with insulin resistance (IR) and diabetes mellitus (DM); however, to our knowledge prior studies have not examined the association of diurnal cortisol curve features with measures of glycemia or IR in a population-based setting. Using log-transformed salivary cortisol data on 850 ethnically diverse men and women from the Multi-Ethnic Study of Atherosclerosis, we investigated the cross-sectional association of cortisol curve features with (1) glycemia in those with and without DM and (2) IR, in non-diabetic subjects. The log-transformed salivary cortisol curve features included wake-up cortisol, cortisol awakening response (CAR), early decline slope (30min to 2h post-awakening), late decline slope (2h post-awakening to bedtime), overall decline slope (0min to bedtime, excluding 30min cortisol), bedtime cortisol and total area under the curve (AUC). Overall, following multivariable adjustment, among those with diabetes mellitus (DM), early decline slope, overall decline slope, bedtime cortisol, and AUC were significantly and positively associated with a 5.4% (95% CI: 1.3, 9.7), 54.7% (95% CI: 12.4, 112.9), 4.0% (95% CI: 1.6,6.4), and 6.8% (95% CI: 3.3,10.4) higher HbA1c per 1 unit increase in log cortisol feature, respectively. Cortisol curve features were not associated with HbA1c among non-diabetic participants; however, wake-up cortisol and AUC were associated with a 8.2% lower (95% CI: -13.3,-2.7) and 7.9% lower (95% CI: -14.6, -0.6) log HOMA-IR, respectively. This was attenuated by adjustment for waist circumference. Among participants with DM, cortisol curve parameters suggestive of higher hypothalamic-pituitary-adrenal (HPA) axis activity and dysfunction were associated with higher HbA1c. In non-diabetic participants, greater HPA activity was paradoxically associated with lower insulin resistance.
皮质醇增多症与胰岛素抵抗(IR)和糖尿病(DM)相关;然而,据我们所知,此前的研究尚未在基于人群的研究中探讨昼夜皮质醇曲线特征与血糖或IR指标之间的关联。利用来自动脉粥样硬化多民族研究的850名不同种族的男性和女性的对数转换唾液皮质醇数据,我们调查了皮质醇曲线特征与(1)患有和未患有DM者的血糖,以及(2)非糖尿病受试者的IR之间的横断面关联。对数转换唾液皮质醇曲线特征包括觉醒时皮质醇、皮质醇觉醒反应(CAR)、早期下降斜率(觉醒后30分钟至2小时)、晚期下降斜率(觉醒后2小时至就寝时间)、总体下降斜率(0分钟至就寝时间,不包括30分钟时的皮质醇)、就寝时皮质醇和曲线下总面积(AUC)。总体而言,经过多变量调整后,在糖尿病(DM)患者中,早期下降斜率、总体下降斜率、就寝时皮质醇和AUC与糖化血红蛋白(HbA1c)显著正相关,每单位对数皮质醇特征增加,HbA1c分别升高5.4%(95%CI:1.3,9.7)、54.7%(95%CI:12.4,112.9)、4.0%(95%CI:1.6,6.4)和6.8%(95%CI:3.3,10.4)。皮质醇曲线特征与非糖尿病参与者的HbA1c无关;然而,觉醒时皮质醇和AUC分别与对数稳态模型评估的胰岛素抵抗(HOMA-IR)降低8.2%(95%CI:-13.3,-2.7)和7.9%(95%CI:-14.6,-0.6)相关。经腰围调整后这种关联减弱。在患有DM的参与者中,提示下丘脑-垂体-肾上腺(HPA)轴活性和功能障碍较高的皮质醇曲线参数与较高的HbA1c相关。在非糖尿病参与者中,较高的HPA活性反而与较低的胰岛素抵抗相关。